【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Erectile Dysfunction Overview 9
Therapeutics Development 10
Pipeline Products for Erectile Dysfunction – Overview 10
Pipeline Products for Erectile Dysfunction – Comparative Analysis 11
Erectile Dysfunction – Therapeutics under Development by Companies 12
Erectile Dysfunction – Therapeutics under Investigation by Universities/Institutes 14
Erectile Dysfunction – Pipeline Products Glance 15
Late Stage Products 15
Clinical Stage Products 16
Early Stage Products 17
Unknown Stage Products 18
Erectile Dysfunction – Products under Development by Companies 19
Erectile Dysfunction – Products under Investigation by Universities/Institutes 21
Erectile Dysfunction – Companies Involved in Therapeutics Development 22
Acorda Therapeutics, Inc. 22
Apricus Biosciences, Inc. 23
Aprogen, Inc. 24
Bioheart, Inc. 25
Biolab Sanus Farmaceutica Ltda. 26
Corridor Pharmaceuticals Inc. 27
Furiex Pharmaceuticals, Inc. 28
Futura Medical plc 29
Hanmi Pharmaceuticals, Co. Ltd. 30
IntelGenx Corp. 31
Mezzion Pharma Co. Ltd. 32
Mitsubishi Tanabe Pharma Corporation 33
NAL Pharmaceuticals Ltd. 34
Pacific Therapeutics Ltd. 35
Palatin Technologies, Inc. 36
Pharmicell Co., Ltd. 37
Sagene Pharmaceuticals, Inc. 38
Suda Ltd 39
Yungjin Pharm Ind. Co., Ltd. 40
Erectile Dysfunction – Therapeutics Assessment 41
Assessment by Monotherapy Products 41
Assessment by Combination Products 42
Assessment by Target 43
Assessment by Mechanism of Action 45
Assessment by Route of Administration 47
Assessment by Molecule Type 49
Drug Profiles 51
AdipoCell – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
alprostadil – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
AP-102 – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
BL-214 – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
cimaglermin alfa – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
dapoxetine hydrochloride – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
HCP-1302 – Drug Profile 62
Product Description 62
Mechanism of Action 62
R&D Progress 62
HCP-1303 – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
Immpocellgram – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
MED-2002 – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
Next Generation Melanocortin Receptor IV Agonist – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
Peptide to Activate G Protein-Coupled Receptor Mas for Cardiovascular, Metabolic Disorders and Erectile Dysfunction – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
PL-6983 – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
selegiline + PDE-5 Inhibitor – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
sildenafil citrate – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
sildenafil citrate – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
sildenafil citrate – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
Small Molecule to Inhibit Arginase for Vascular Dysfunction, PAH and Erectile Dysfunction – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
T-6932 – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
tadalafil – Drug Profile 77
Product Description 77
Mechanism of Action 77
R&D Progress 77
tadalafil – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
TPN-729 – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
udenafil – Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
YBH-1603 – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
Erectile Dysfunction – Recent Pipeline Updates 83
Erectile Dysfunction – Dormant Projects 94
Erectile Dysfunction – Discontinued Products 97
Erectile Dysfunction – Product Development Milestones 98
Featured News & Press Releases 98
Feb 24, 2014: IntelGenx Achieves Positive Bioequivalence Results for Erectile Dysfunction VersaFilm Tadalafil Product 98
Aug 28, 2012: Acorda Announces GGF2 Preclinical Data On Treatment Of Erectile Dysfunction 98
Jul 18, 2012: Zydus Urosciences Launches Udenafil For Treatment Of Erectile Dysfunction In India 99
Sep 08, 2011: Sagene Completes Pre-IND Meeting With FDA For Dual-Action Erectile Dysfunction Drug 99
Oct 12, 2010: Dong-A Launches Zydena For Daily Treatment Of Erectile Dysfunction In Korea 100
Sep 02, 2010: IntelGenx Achieves Positive Bioequivalence Results For Erectile Dysfunction Film Product 100
Nov 19, 2009: Once-A-Day Dosing Clinical Study Of Udenafil For Erectile Dysfunction Completed By Dong-A Pharmaceutical Co., Ltd. 100
Nov 11, 2009: ZYDENA Poised To Enter Global Market With Phase III Clinical Trial Starting For US FDA Approval 101
Sep 11, 2009: New Drug Udenafil By Dong-A PharmTech Co. Ltd For Erectile Dysfunction in US Trials 102
Aug 28, 2009: Dong-A Receives Approval For Zydena For Treatment Of Erectile Dysfunction 102
Appendix 103
Methodology 103
Coverage 103
Secondary Research 103
Primary Research 103
Expert Panel Validation 103
Contact Us 104
Disclaimer 104
【レポート販売概要】
■ タイトル：勃起不全(Erectile Dysfunction)の治療薬パイプライン動向（2015年上半期版）■ 英文：Erectile Dysfunction - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6047IDB
■ 調査対象地域：グローバル
- 世界のリン酸塩市場：市場規模、動向、メーカー動向Scope The report presents a thorough study of phosphates, covering both global and regional markets It aims to give a proper picture of the market, as well as its trends, perspectives and opportunities Comprehensive data showing phosphates production, consumption, trade statistics and prices are provided (both nationwide and worldwide) Each country’s market overview covers the following: phosphate …
- リソグラフィー計測機器の世界市場：技術別（CD-SEM、OCD、オーバーレイ制御、その他）、製品別（化学制御機器、ガス制御機器、その他）、用途別（品質管理と検査、リバースエンジニアリング、仮想シミュレーション、その他）The semiconductor industry is continuously witnessing transition such as miniaturization of nodes and wafer sizes. The rise in demand for increasing wafer sizes into ultra-large-scale integration fabrication technology fosters the growth of the lithography metrology equipment market globally. Lithography metrology is a front-end process in semiconductor industry, which is used in fabrication. This …
- コカミドDEAの世界市場2015Cocamide DEA (CAS 8051-30-7) Market Research Report 2015 aims at providing comprehensive data on Cocamide DEA market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Cocamide DEA description, covers its application areas, manufacturing methods, patterns. It captures Cocamide DEA market trends, pays close attention to Cocamide DEA manufacturers and names …
- 心臓バイオマーカーの世界市場：トロポニン、BNP/NT-proBNP、CK-MB、ミオグロビンAbout Cardiac Biomarker A cardiac biomarker is defined as a measurable substance that is an indicator used in the diagnosis and risk stratification related to cardiovascular disease (CVDs) such as acute coronary syndrome (ACS), coronary syndromes, myocardial infarction (MI), and heart failure. Some of the cardiac biomarkers include creatine kinase (CK) MB, troponins (cTnI and cTnT), BNP, NT-proBNP …
- Mobile Handsets and Applications September 2010The Mind Commerce Mobile Handsets and Application report focuses on recent news and events in the Mobile Handset market. The Newsletter brings you stories on the major players and devices in the Cellular Handset industry. We will monitor the trends in the Smartphone market; examine new technology trends and their impact on the marketplace. We study and comment on press announcements from Apple, An …
- IPマルチメディアサブシステムの課題及び機会（IP Multimedia Subsystem (IMS) Challenges and Opportunities in Multi-Application Environment）IP Multimedia Subsystem (IMS) represents a framework for development, deployment, and operation of various applications for support of any-network, any-device, and service provider usage. IMS consists of standards based technologies, architecture, and network elements that bring telephony type control to Internet based applications. The long-term promise of IMS is that it will dramatically simplif …
- 空港及びマリンポートのセキュリティ市場（世界市場予測と分析）Airports and seaports are the foundations of global economy for transporting goods efficiently and swiftly. They are also on the top of the list of potential threats. Their potential to import explosives, chemical materials, and weapons has become a threat to the global community. Seaports represent the weakest point in the chain as open seas. The ports always are vulnerable with the threat of ris …
- 組み込みソフトウェアのグローバル市場（2014-2018）About Embedded Software Embedded software is computer programming written on computer chips that is applied in real-time systems like teller machines, missiles, and airplanes. Moreover, it is software which is combined or stored in computer hardware or a peripheral device. This software is usually developed for special-purpose hardware that uses real-time operating systems such as LynxOS, VxWorks, …
- 洗濯物折り畳みロボットの世界市場2018-2022About Laundry Folding Robots Laundry folding robots are designed to fold clothes. The robots are equipped with sensors to identify the cloth and fold accordingly. Technavio’s analysts forecast the Global Laundry Folding Robots Market to grow at a CAGR of 45.01% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the Global Laundry …
- 民間航空機解体/分解/リサイクルの世界市場Visiongain assesses that the commercial aircraft disassembly, dismantling & recycling market will reach $5,464.1m in 2015. Aircraft retirements and a demand for parts to support aftermarket and maintenance services are two of the leading factors that are expected to drive this market. The market is highly fragmented with a number of leading and smaller players that engage in various activities ass …
- 世界の圧迫療法市場動向（2012-2016）TechNavio's analysts forecast the Global Compression Therapy market to grow at a CAGR of 5.11 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the aging population. The Global Compression Therapy market has also been witnessing an increasing adoption of product bundling strategy. However, the intense competition among vendors could pos …
- 巻線の世界市場2019-2023Global Winding Wire Market: About this market Technavio’s winding wire market analysis considers sales from both copper and aluminum winding wires. Our analysis also considers the sales of winding wire in APAC, Europe, North America, South America, and MEA. In 2018, the copper segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as h …
- 医療レポート：Asthma-疫学予測（～2022）EpiCast Report: Asthma - Epidemiology Forecast to 2022 Summary Asthma is one of the most common chronic diseases in the world, with an estimated 300 million people suffering from the disease in 2004 (Masoli et al., 2004). The 2004 Global Initiative for Asthma (GINA) report estimated that prevalence of asthma in the general population varied widely in different countries around the world, with prop …
- 米州のスマートマシン市場：エキスパートシステム、自律ロボット、デジタルアシスタントAbout the Smart Machines Market in the Americas Smart machines have cognitive computing ability, and use artificial intelligence (AI) and machine learning algorithms to sense, learn, reason, and interact with humans. They offer desired output and solve problems accurately and precisely. The rising concept of Industry 4.0 that include automation, IoT, cloud computing, and smart machines in the auto …
- オーストラリアの原子力産業分析：Analyzing Nuclear Power in AustraliaAustralia is unique in having a range of energy resources; fossil fuel, oil and uranium as well as a variety of potential sources of renewable energy (wind, water etc). Although Federal and state government policies on matters nuclear have frequently changed direction, a constant feature of the debate over this period has been the fervor with which proponents and opponents have presented their vie …
